48.5
Purple Biotech Ltd. ADR
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
33.3
FY23:
15.8
FY24:
8.91
FY25:
9.87
(positive)
Change from FY21 to FY25
millions USD
FY21:
21.7
FY22:
21.4
FY23:
28.5
FY24:
28.1
FY25:
7.71
Total assets
Change from FY21 to FY25
millions USD
FY21:
70.2
FY22:
54.6
FY23:
44.3
FY24:
37.0
FY25:
17.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.25
FY22:
7.06
FY23:
9.70
FY24:
3.99
FY25:
7.75
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.84
FY22:
0.47
FY23:
2.82
FY24:
0.14
FY25:
0.16
(positive)
Change from FY21 to FY25
millions USD
FY21:
65.1
FY22:
47.1
FY23:
34.3
FY24:
32.9
FY25:
9.66
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
70.2
FY22:
54.6
FY23:
44.3
FY24:
37.0
FY25:
17.6
All amounts in millions USD